| Mar 28, 2024 | PYXSPyxis Oncology, Inc. | SLSullivan Lara Chief Executive Officer · Director | Holdings only | — | — | — | |
| Mar 28, 2024 | PYXSPyxis Oncology, Inc. | CPConnealy Pamela Ann CFO & COO | AGrant | 328,710 | $0.00 | $0 | |
| Mar 28, 2024 | MHHMastech Digital, Inc. | WGWatzinger Gerhard Director | AGrant | 7,403 | $0.00 | $0 | |
| Mar 28, 2024 | MHHMastech Digital, Inc. | GB | AGrant | 7,403 | $0.00 | $0 | |
| Mar 28, 2024 | MHHMastech Digital, Inc. | AJ | AGrant | 7,403 | $0.00 | $0 | |
| Mar 28, 2024 | MHHMastech Digital, Inc. | RV | AGrant | 7,403 | $0.00 | $0 | |
| Mar 28, 2024 | EVBGEVERBRIDGE, INC. | RDRockvam David E Chief Financial Officer | Holdings only | — | — | — | |
| Mar 28, 2024 | HBIHanesbrands Inc. | BSBratspies Stephen B Chief Executive Officer · Director | AGrant | 578,358 | $0.00 | $0 | |
| Mar 28, 2024 | HBIHanesbrands Inc. | RVRobinson Vanessa LeFebvre President, Activewear - Global | AGrant | 93,284 | $0.00 | $0 | |
| Mar 28, 2024 | HBIHanesbrands Inc. | CJCavaliere Joseph W President, Innerwear - Global | AGrant | 164,179 | $0.00 | $0 | |
| Mar 28, 2024 | JILLJ.Jill, Inc. | RM | SSale | 5,000 | $32.30 | $161,500 | |
| Mar 28, 2024 | HBIHanesbrands Inc. | PSPleiman Scott A See Remarks | AGrant | 74,627 | $0.00 | $0 | |
| Mar 28, 2024 | HBIHanesbrands Inc. | FMFaircloth Michael E. EVP, Supply Chain - Global | AGrant | 103,134 | $0.00 | $0 | |
| Mar 28, 2024 | HBIHanesbrands Inc. | LMLewis Markland Scott See Remarks | AGrant | 111,940 | $0.00 | $0 | |
| Mar 28, 2024 | HBIHanesbrands Inc. | OKOliver Kristin L See Remarks | AGrant | 93,284 | $0.00 | $0 | |
| Mar 28, 2024 | TKOTKO Group Holdings, Inc. | MVMCMAHON VINCENT K 10% Owner | JOther | 3,484,006 | — | — | |
| Mar 28, 2024 | PXP10, Inc. | JRJensen Richard J. EVP, Head of Strategy and M&A | PPurchase | 55,000 | $8.35 | $459,250 | |
| Mar 28, 2024 | KKELLANOVA | KWKELLOGG W K FOUNDATION TRUST 10% Owner (+1) | SSale | 77,800 | $57.3397 | $4,461,029 | |
| Mar 28, 2024 | IGMSIGM Biosciences, Inc. | BBBAKER BROS. ADVISORS LP Director · 10% Owner (+5) | PPurchase | 247,656 | $8.2621 | $2,046,159 | |
| Mar 28, 2024 | NAStarwood Real Estate Income Trust, Inc. | DMDeason Mark See Remarks · Director | AGrant | 18,075 | — | — | |
| Mar 28, 2024 | NAStarwood Real Estate Income Trust, Inc. | DMDeason Mark See Remarks · Director | AGrant | 3,460 | — | — | |
| Mar 28, 2024 | NAStarwood Real Estate Income Trust, Inc. | NA | AGrant | 25,162 | — | — | |
| Mar 28, 2024 | NAStarwood Real Estate Income Trust, Inc. | MJMcCarthy John Patrick Vice Chairman of the Board · Director | AGrant | 40,784 | — | — | |
| Mar 28, 2024 | NAStarwood Real Estate Income Trust, Inc. | HS | AGrant | 39,938 | — | — | |
| Mar 28, 2024 | NAStarwood Real Estate Income Trust, Inc. | GMGuttin Matthew S See Remarks | AGrant | 7,081 | — | — | |
| Mar 28, 2024 | NAStarwood Real Estate Income Trust, Inc. | LCLowthert Chris Chief Financial Officer | AGrant | 6,773 | — | — | |
| Mar 28, 2024 | RNGRRanger Energy Services, Inc. | LCLeykum Charles S. Director · 10% Owner (+1) | SSale | 132,000 | $11.08 | $1,462,560 | |
| Mar 28, 2024 | LSXMALiberty Media Corp | BHBERKSHIRE HATHAWAY INC 10% Owner (+1) | PPurchase | 7,378,500 | $29.0997 | $214,712,136 | |
| Mar 28, 2024 | LSXMALiberty Media Corp | BWBUFFETT WARREN E 10% Owner (+1) | PPurchase | 2,331,514 | $29.1002 | $67,847,524 | |
| Mar 28, 2024 | EPIXESSA Pharma Inc. | CACesano Alessandra Chief Medical Officer | Holdings only | — | — | — | |
| Mar 28, 2024 | EPIXESSA Pharma Inc. | PDParkinson David Ross Chief Executive Officer · Director | Holdings only | — | — | — | |
| Mar 28, 2024 | EPIXESSA Pharma Inc. | VPVirsik Peter Chief Operating Officer | Holdings only | — | — | — | |
| Mar 28, 2024 | EPIXESSA Pharma Inc. | WDWood David S. Chief Financial Officer | Holdings only | — | — | — | |
| Mar 28, 2024 | EPIXESSA Pharma Inc. | BFBERGER FRANKLIN M Director | Holdings only | — | — | — | |
| Mar 28, 2024 | EPIXESSA Pharma Inc. | GRGlickman Richard M Director | Holdings only | — | — | — | |
| Mar 28, 2024 | EPIXESSA Pharma Inc. | KPKantoff Philip W. Director | Holdings only | — | — | — | |
| Mar 28, 2024 | EPIXESSA Pharma Inc. | MJMartin John Alexander Director | Holdings only | — | — | — | |
| Mar 28, 2024 | EPIXESSA Pharma Inc. | ML | Holdings only | — | — | — | |
| Mar 28, 2024 | EPIXESSA Pharma Inc. | RS | Holdings only | — | — | — | |
| Mar 28, 2024 | EPIXESSA Pharma Inc. | SG | Holdings only | — | — | — | |
| Mar 28, 2024 | EPIXESSA Pharma Inc. | TM | Holdings only | — | — | — | |
| Mar 28, 2024 | EPIXESSA Pharma Inc. | ZSZWEIFACH SANFORD S Director | Holdings only | — | — | — | |
| Mar 28, 2024 | HUTHut 8 Corp. | SMSHATTUCK MAYO A III Director | Holdings only | — | — | — | |
| Mar 28, 2024 | HUTHut 8 Corp. | OE | Holdings only | — | — | — | |
| Mar 28, 2024 | HUTHut 8 Corp. | TW | Holdings only | — | — | — | |
| Mar 28, 2024 | FPHFive Point Holdings, LLC | LCLuxor Capital Group, LP 10% Owner (+5) | SSale | 3,938 | $3.1855 | $12,544 | |
| Mar 28, 2024 | DGXQUEST DIAGNOSTICS INC | PPPlewman Patrick SVP for Diagnostic Services | FTax | 114 | $128.11 | $14,605 | |
| Mar 28, 2024 | DGXQUEST DIAGNOSTICS INC | DMDELANEY MARK E SVP & Chief Commercial Officer | FTax | 170 | $128.11 | $21,779 | |
| Mar 28, 2024 | PXDPIONEER NATURAL RESOURCES CO | GP | SSale | 2,000 | $261.121 | $522,242 | |
| Mar 28, 2024 | PXDPIONEER NATURAL RESOURCES CO | WCWashburn Christopher L VP & CAO | SSale | 1,416 | $260.955 | $369,512 | |